Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab

Ucan Gunduz G., Yalcinbayir Ö., Cekic Ş., Yildiz M., Kilic S. Ş.

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, cilt.37, sa.4, ss.236-240, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 37 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1089/jop.2020.0081
  • Dergi Adı: JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, BIOSIS, CAB Abstracts, Chemical Abstracts Core, CINAHL, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.236-240
  • Anahtar Kelimeler: adalimumab, infliximab, noninfectious, pediatric, uveitis
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Purpose: Management of uveitis displays a particular challenge in childhood. This study aims to compare the efficacy and safety of infliximab (IFX) and adalimumab (ADA) in pediatric noninfectious uveitis that were refractory to conventional immunosuppresives.